Qualification: M.Sc. (Microbiology) & Ph.D (Biochemistry)

Dr. Shuvojit Moulik is a distinguished scientist with over 15 years of experience in cancer biology, with a particular focus on gynecological cancers. His research expertise encompasses cell signaling pathways, genetic mutations, and receptor biology, and he is proficient in a wide array of laboratory and analytical techniques. These include diagnostic assays, protein–protein interaction methods, and advanced microscopy, which he employs to uncover molecular mechanisms underlying cancer progression and therapeutic resistance. In addition to his scientific career, Dr. Moulik brings 14 years of interdisciplinary research and social engagement, bridging healthcare, disability rights, gender equality, and education for marginalized communities. He is the founder of the Civilian Welfare Foundation (CWF), through which he has initiated and led numerous projects that merge scientific insight with grassroots implementation. His work exemplifies a unique integration of biomedical research and social commitment, to advance both scientific innovation and societal well-being.

Thrust areas: 

• Affordable cancer diagnostics and screening (HRD, HPV)  
• Precision oncology and resistance biology  
• Integrative oncology adjuncts from traditional medicine  
• Palliative care and quality-of-life research using confocal imaging, 3D cultures, and phospho-proteomics.  
• Geo-clustered biorepositories for women’s cancers integrating clinical, molecular, and mental–physical data.
• Health equity for marginalized groups via point-of-care molecular diagnostics (HPV/HBV), trans-affirmative care, and PAR-driven delivery.  
• Neurohealth and disability: Parkinson’s mitochondrial probes, early neurodivergence biomarkers, arts- and sports-based therapeutics (women athletes).

Publications (22) :

1. Karmakar S, Dutta R, Das E, Patra M, Kar A, Moulik S. Association of Cytomegalo Virus Seropositivity with Depression, Anxiety, General Well-Being and Pain Among the LGBTQIA+ Population: A Cross-Sectional Transdisciplinary Study, East Asian Archives of Psychiatry, December 2025. (Communicated) 
2. Dahiya N, Rautela RS, Salhotra R, Banerjee A, Dutta R, Moulik S. Analgesic efficacy of Intrathecal Nalbuphine versus Buprenorphine as an adjuvant to Levobupivacaine in patients undergoing elective lower abdominal surgeries: A randomised controlled trial, Journal of Research in Clinical Medicine, December 2025. (Communicated) 
3. Sengupta S, Karmakar S, Moulik S. Cell and Molecule-Mediated Drug Delivery Systems with Spatiotemporal Control for Osteochondral Regeneration: A Systematic Review of Advancements, Synergies, and Translational Challenges, Pharmaceutics, November 2025.  
4. Sengupta S, Bhattacharjee A, Basu B, Kar S, Moulik S Ultrasound mediated nanocarrier based drug delivery in Breast Cancer Therapy: Innovations and Outlook, Journal of Ultrasound Medicine, November 2025 
5. Karmakar S, Dutta R, Moulik S Transdisciplinary Analysis of Human Papilloma Virus, Discover Medicine (Accepted Feb 2025) 
6. Moulik S, Karmakar S, Basu A, Ali M, Chatterjee A. Interdependency and differential expression of ERK1 and 
7. ERK2 in breast and melanoma cell lines. Journal of Egyptian National Cancer Institute, October 2024 
8. Ganguly OM-Moulik S. Interactions of Mn complexes with DNA: the relevance of therapeutic applications towards cancer treatment. Dalton Transactions. 2023 June 
9. Moulik S, Karmakar S, Basu A, Mukherjee S, Neeraja R, Chatterjee A. Studies of ERK1/2 with Respect to Tumor Aggressiveness in B16F10 Murine Melanoma Cells. International Journal for Multidisciplinary Research (IJFMR). 2023 February 5 (1): 1-28 
10. Basu A, Moulik S, Karmakar S. Bioaccumulation of different organic micropollutant in fishes and its toxicological stress impacts: A review. International Journal for Research in applied science & engineering and Technology (iJRASET). 2023 February 11(2): 1549-1564 
11. Bhattacharya N-Mondal-Moulik S, Paul S, Bhattacharya S, Hazra A K, Ali N, Chatterjee A. Effect of Black Tea Polyphenol on Cell-ECM Interaction and MMP. American Journal of Plant Sciences. 2017 March 30 (8):856-866 
12. Sil H, Moulik S, Singha I, Mandal S S, Biswas J, Chatterjee A. Activation of Matrix Metalloproteinase 2(MMP- 2) in Breast Cancer Progression. Journal of Tumor. 2015 Feb 18 3(1): 292-304 
13. Moulik S, Chatterjee A. Role of ERK1/2 in modulating MMP 2 and MMP9 with respect to tumour invasiveness in human cancer cell line MCF 7 and MDAMB231. Journal of Tumor. 2014. Jan.2(1):53-61 
14. Pal S, Moulik S, Dutta A and Chatterjee A. Extracellular Matrix Protein Laminin Induces Matrix Metalloproteinase-9 in Human Breast Cancer Cell Line MCF-7. Cancer Microenvironment. 2014. May. 1875- 2292 
15. Moulik S, Sen T, Dutta A, Banerji A, Ghosh C, Das S, and Chatterjee A. Phosphatidylinositol 3-Kinase and NF- kB Involved in Epidermal Growth Factor-Induced Matrix Metalloproteinase-9 Expression. 2008 J. Cancer Mol. 4: 55-60 
16. Moulik S, Chatterjee A. Vascular endothelial growth factor (VEGF) & tumour angiogenesis. Indian J Med Res. 2007 Jun; 125(6):715-6. 
17. ​​​​​​​Nanda-Sil, Moulik S, Biswas J, Mandal Chatterjee A. Matrix Metalloproteinase-9 as a Potential Tumor Marker in Breast Cancer. Journal of Environmental Pathology Toxicology and Oncology.2013. 32(2):115-129 
18. ​​​​​​​Ganguly K, Pal S, Moulik S. Integrin and Metastasis. Cell Adhesion Migration. Jan 2013 .7(3). 
19. ​​​​​​​Pal S, Ganguly KK, Moulik S, Chatterjee A. Modulation of MMPs by cell surface integrin receptor α5β1. Anticancer Agents Med Chem. 2012 Sep; 12(7):726-32. 
20. ​​​​​​​Sil H, Sen T, Moulik S, Chatterjee A. Black tea polyphenol (theaflavin) downregulates MMP-2 in human melanoma cell line A375 by involving multiple regulatory molecules. J Environ PatholToxicolOncol. 2010; 29(1):55-68. 
​​​​​​​21. ​​​​​​​Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S, Roy M, Chatterjee A. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in down regulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci. 2009 Feb 13; 84(7-8):194-204. 
22. ​​​​​​​Adhikary D, Brahmachary B, Kar A & Moulik S. Sports and Social Capital: A Qualitative Study on Women Athletes with Disabilities. IRJMS Sep 2020 
23. ​​​​​​​Biswas A, Pal D & Moulik S. Managing the Covid 19 life: A study on the impact of the pandemic on athlete with intellectual and developmental disabilities. Int Research Journal for Multidisciplinary scope, July 2021 
24. ​​​​​​​​​​​​​​Marginalization and Discrimination in Queer Rural Livelihoods: Evidence from Agricultural Workers in West Bengal. Journal of Homosexuality, December 2025. (Abstract Communicated) 

Manuscripts in Preparation 

1. ​​​​​​​Moulik S , Karmakar S, kar A, Mondol C, Mukhopadhya A. Ovarian cancer specific biobanking in eastern india Population. Biopreservation & biobanking journal. (Submitted July 2023) 
2. ​​​​​​​Moulik S, Bhattachrya A, Dutta R. Mental Health status in Trans-affirmative Healthcare in India 
3. ​​​​​​​Ghosh S, Dasgupta A, Pal D, Dutta R, Dey A, Moulik S. The Prolonged Impact of Covid-19 on Athletes with Disabilities: A Qualitative Study. European Journal of Adapted Physical Activity. (Submitted August 2024) 
4. ​​​​​​​Dutta R, Das E, Sarkar N, Pal D, Sanyal S, Moulik S. Exploring the Psychological and Behavioral Impacts of Unified Theatre as an Inclusive Performing Art on Empowerment and Social Inclusion for Individuals with and without Intellectual Disabilities. Journal of Creative Behaviour. (Submitted October 2025). 
​​​​​​​5. ​​​​​​​Juneja, S., Misra, S., Dutta, R., Das, A., Batra, A., Banerjee, B.D., Moulik, S. Celiac Disease and Depression: Findings from an Association Study in North India. Indian Journal of Psychiatry. (Submitted September 2025).